{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:36:23Z","timestamp":1781278583373,"version":"3.54.1"},"reference-count":70,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCAS"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.4103\/jcas.jcas_212_22","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T09:00:46Z","timestamp":1683882046000},"page":"71-80","source":"Crossref","is-referenced-by-count":3,"title":["Combination and rotational therapy in androgenetic alopecia"],"prefix":"10.25259","volume":"16","author":[{"given":"Venkatram","family":"Mysore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthuvel","family":"Kumaresan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuken","family":"Dashore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniketh","family":"Venkatram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"CIT0001-20230512","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5021\/ad.2017.29.1.55","article-title":"The Advantage of Cyclosporine A and Methotrexate Rotational Therapy in long-term systemic treatment for chronic plaque psoriasis in a real world practice","volume":"29","author":"Choi","year":"2017","journal-title":"Ann Dermatol"},{"key":"CIT0002-20230512","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0190-9622(93)70067-4","article-title":"An approach to the treatment of moderate to severe psoriasis with rotational therapy","volume":"28","author":"Weinstein","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"CIT0003-20230512","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update \u03bfn the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"CIT0004-20230512","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1046\/j.1365-2230.2001.00829.x","article-title":"Therapeutic strategies: Rotational therapy and combinations","volume":"26","author":"van de Kerkhof","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"CIT0005-20230512","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.fertnstert.2019.11.030","article-title":"Post-finasteride syndrome: A surmountable challenge for clinicians","volume":"113","author":"Traish","year":"2020","journal-title":"Fertil Steril"},{"key":"CIT0006-20230512","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.abd.2020.02.001","article-title":"Post-finasteride syndrome","volume":"95","author":"Pereira","year":"2020","journal-title":"An Bras Dermatol"},{"key":"CIT0007-20230512","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/13685538.2018.1548589","article-title":"Post-finasteride syndrome - does it really exist?","volume":"22","author":"Maksym","year":"2019","journal-title":"Aging Male"},{"key":"CIT0008-20230512","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/bjd.12921","article-title":"Destruction of the arrector pili muscle and fat infiltration in androgenic alopecia","volume":"170","author":"Torkamani","year":"2014","journal-title":"Br J Dermatol"},{"key":"CIT0009-20230512","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000246309","article-title":"Anagen hairs may fail to replace telogen hairs in early androgenic female alopecia","volume":"192","author":"Guarrera","year":"1996","journal-title":"Dermatology"},{"issue":"F1000 Faculty Rev","key":"CIT0010-20230512","doi-asserted-by":"crossref","first-page":"585","DOI":"10.12688\/f1000research.6401.1","article-title":"Androgenetic alopecia: New insights into the pathogenesis and mechanism of hair loss","volume":"4","author":"Sinclair","year":"2015","journal-title":"F1000Res"},{"key":"CIT0011-20230512","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archderm.138.8.1101","article-title":"Androgenetic alopecia: Analysis of proliferation and apoptosis","volume":"138","author":"Prieto","year":"2002","journal-title":"Arch Dermatol"},{"key":"CIT0012-20230512","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/bmj.317.7162.865","article-title":"Male pattern androgenetic alopecia","volume":"317","author":"Sinclair","year":"1998","journal-title":"BMJ"},{"key":"CIT0013-20230512","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1067\/mjd.2001.117428","article-title":"Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss","volume":"45","author":"Whiting","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"CIT0014-20230512","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jdv.14624","article-title":"Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version","volume":"32","author":"Kanti","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"CIT0015-20230512","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/0378-6323.177432","article-title":"Guidelines on the use of finasteride in androgenetic alopecia","volume":"82","author":"Mysore","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"CIT0016-20230512","first-page":"457","article-title":"A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women","volume":"17","author":"Lee","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"Suppl 1","key":"CIT0017-20230512","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/idoj.idoj_328_21","article-title":"Platelet-rich plasma in androgenetic alopecia","volume":"12","author":"Sharma","year":"2021","journal-title":"Indian Dermatol Online J"},{"key":"CIT0018-20230512","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.3390\/ijms21082702","article-title":"Systematic review of platelet-rich plasma use in androgenetic alopecia compared with minoxidil\u00ae, finasteride\u00ae, and adult stem cell-based therapy","volume":"21","author":"Gentile","year":"2020","journal-title":"Int J Mol Sci"},{"key":"CIT0019-20230512","first-page":"265","article-title":"Hair transplant practice guidelines","volume":"14","author":"Mysore","year":"2021","journal-title":"J CutanAesthet Surg"},{"key":"CIT0020-20230512","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1210\/jc.2003-030330","article-title":"Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor","volume":"89","author":"Clark","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"CIT0021-20230512","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1574884712666170310111125","article-title":"Dutasteride in androgenetic alopecia: An update","volume":"12","author":"Arif","year":"2017","journal-title":"Curr Clin Pharmacol"},{"key":"CIT0022-20230512","first-page":"203","article-title":"A review of current data on a novel dual inhibitor of 5\u03b1 reductase","volume":"7","author":"Marihart","year":"2005","journal-title":"Rev Urol"},{"key":"CIT0023-20230512","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2125.1999.00843.x","article-title":"The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination","volume":"47","author":"Gisleskog","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"CIT0024-20230512","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/CIA.S192435","article-title":"The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: A systematic review and meta-analysis","volume":"14","author":"Zhou","year":"2019","journal-title":"Clin Interv Aging"},{"key":"CIT0025-20230512","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003495-199957010-00014","article-title":"Finasteride: A review of its use in male pattern hair loss","volume":"57","author":"McClellan","year":"1999","journal-title":"Drugs"},{"key":"CIT0026-20230512","first-page":"400","article-title":"Long-term treatment with finasteride 1\u2009mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss)","volume":"18","author":"Kaufman","year":"2008","journal-title":"Eur J Dermatol"},{"key":"CIT0027-20230512","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1529-8019.2011.01441.x","article-title":"Finasteride, 1\u2009mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up","volume":"24","author":"Rossi","year":"2011","journal-title":"Dermatol Ther"},{"key":"CIT0028-20230512","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/1346-8138.14719","article-title":"Evaluation of long-term efficacy of finasteride in korean men with androgenetic alopecia using the basic and specific classification system","volume":"46","author":"Shin","year":"2019","journal-title":"J Dermatol"},{"key":"CIT0029-20230512","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/1346-8138.12890","article-title":"Five-year efficacy of finasteride in 801 Japanese men with androgenetic alopecia","volume":"42","author":"Yoshitake","year":"2015","journal-title":"J Dermatol"},{"key":"CIT0030-20230512","first-page":"550","article-title":"The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia","volume":"41","author":"Drake","year":"1999","journal-title":"J Am Acad of Dermatol"},{"key":"CIT0031-20230512","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1210\/jcem-70-4-1136","article-title":"Effects of finasteride (MK-906), a 5\u03b1-reductase inhibitor, on circulating androgens in male volunteers","volume":"70","author":"Gormley","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"CIT0032-20230512","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.fertnstert.2004.02.118","article-title":"Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women","volume":"82","author":"Tartagni","year":"2004","journal-title":"Fertil Steril"},{"key":"CIT0033-20230512","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0090-4295(02)02401-9","article-title":"Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia","volume":"61","author":"Wessells","year":"2003","journal-title":"Urology"},{"key":"CIT0034-20230512","doi-asserted-by":"crossref","first-page":"e3020","DOI":"10.7717\/peerj.3020","article-title":"Persistent erectile dysfunction in men exposed to the 5\u03b1-reductase inhibitors, finasteride, or dutasteride","volume":"5","author":"Kiguradze","year":"2017","journal-title":"PeerJ"},{"key":"CIT0035-20230512","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1743-6109.2011.02255.x","article-title":"Persistent sexual side effects of finasteride for male pattern hair loss","volume":"8","author":"Irwig","year":"2011","journal-title":"J Sex Med"},{"key":"CIT0036-20230512","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1111\/j.1743-6109.2012.02846.x","article-title":"Persistent sexual side effects of finasteride: Could they be permanent?","volume":"9","author":"Irwig","year":"2012","journal-title":"J Sex Med"},{"key":"CIT0037-20230512","doi-asserted-by":"crossref","first-page":"e3020","DOI":"10.7717\/peerj.3020","article-title":"Persistent erectile dysfunction in men exposed to the 5\u03b1-reductase inhibitors, finasteride, or dutasteride","volume":"5","author":"Kiguradze","year":"2017","journal-title":"PeerJ"},{"key":"CIT0038-20230512","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00128071-200708050-00003","article-title":"Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: A randomized, double-blind, comparative clinical trial","volume":"8","author":"Shin","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"CIT0039-20230512","doi-asserted-by":"crossref","first-page":"90","DOI":"10.18311\/mvpjms\/2015\/v2\/i2\/781","article-title":"Comparative study of efficacy of topical minoxidil 5% and combination of topical minoxidil 5%, topical azelaic acid 1.5% and topical tretinoin 0.01% on the basis of dermoscopic analysis in androgenetic alopecia","volume":"2","author":"Gugle","year":"2015","journal-title":"MVP Journal of Med Sci"},{"key":"CIT0040-20230512","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0190-9622(90)70089-Z","article-title":"Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil","volume":"22","author":"Olsen","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"CIT0041-20230512","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40257-014-0077-5","article-title":"Androgenetic alopecia: An evidence-based treatment update","volume":"15","author":"Varothai","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"CIT0042-20230512","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0190-9622(87)70092-9","article-title":"Long-term efficacy of topical minoxidil in male pattern baldness","volume":"16","author":"Katz","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"CIT0043-20230512","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0190-9622(99)70006-X","article-title":"Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment","volume":"41","author":"Price","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"CIT0044-20230512","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0190-9622(90)70089-Z","article-title":"Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil","volume":"22","author":"Olsen","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"CIT0045-20230512","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0190-9622(87)70179-0","article-title":"Topical minoxidil in male pattern baldness: Effects of discontinuation of treatment","volume":"17","author":"Olsen","year":"1987","journal-title":"J Am Acad of Dermatol"},{"key":"CIT0046-20230512","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/jps.2600790605","article-title":"Relationship between contact time of applied dose and percutaneous absorption of minoxidil from a topical solution","volume":"79","author":"Ferry","year":"1990","journal-title":"J Pharm Sci"},{"key":"CIT0047-20230512","first-page":"187","article-title":"Topical minoxidil in androgenetic alopecia, how good is it?","volume":"56","author":"Kubba","year":"1990","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"CIT0048-20230512","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/187221312800166859","article-title":"Minoxidil use in dermatology, side effects and recent patents","volume":"6","author":"Rossi","year":"2012","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"CIT0049-20230512","first-page":"1153","article-title":"Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil","volume":"30","author":"McCoy","year":"2016","journal-title":"J Biol Regul Homeost Agents"},{"key":"CIT0050-20230512","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.2147\/DDDT.S214907","article-title":"Minoxidil and its use in hair disorders: A review","volume":"13","author":"Suchonwanit","year":"2019","journal-title":"Drug Design, Development and Therapy"},{"issue":"Suppl 1","key":"CIT0051-20230512","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.4103\/idoj.idoj_269_21","article-title":"Preparation of platelet-rich plasma: National IADVL PRP taskforce recommendations","volume":"12","author":"Dashore","year":"2021","journal-title":"Indian Dermatol Online J"},{"key":"CIT0052-20230512","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/dsu.12292","article-title":"Promotional effect of platelet-rich plasma on hair follicle reconstitution in vivo","volume":"39","author":"Miao","year":"2013","journal-title":"Dermatol Surg"},{"key":"CIT0053-20230512","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41598-017-01105-8","article-title":"As a carrier-transporter for hair follicle reconstitution, platelet-rich plasma promotes proliferation and induction of mouse dermal papilla cells","volume":"7","author":"Xiao","year":"2017","journal-title":"Sci Rep"},{"key":"CIT0054-20230512","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5966\/sctm.2015-0107","article-title":"The effect of platelet-rich plasma in hair regrowth: A randomized placebo-controlled trial","volume":"4","author":"Gentile","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"CIT0055-20230512","first-page":"13030\/qt8s43026c","article-title":"Platelet-rich plasma for androgenic alopecia treatment: A comprehensive review","volume":"24","author":"Girijala","year":"2018","journal-title":"Dermatol Online J"},{"key":"CIT0056-20230512","first-page":"213","article-title":"Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period","volume":"7","author":"Gkini","year":"2014","journal-title":"J CutanAesthet Surg"},{"key":"CIT0057-20230512","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijwd.2018.08.004","article-title":"Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol","volume":"5","author":"Stevens","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"CIT0058-20230512","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/DSS.0000000000000665","article-title":"Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia","volume":"42","author":"Alves","year":"2016","journal-title":"Dermatol Surg"},{"key":"CIT0059-20230512","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.mito.2004.07.033","article-title":"Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy","volume":"4","author":"Eells","year":"2004","journal-title":"Mitochondrion"},{"key":"CIT0060-20230512","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s10439-011-0454-7","article-title":"The nuts and bolts of low-level laser (light) therapy","volume":"40","author":"Chung","year":"2012","journal-title":"Ann Biomed Eng"},{"key":"CIT0061-20230512","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/lsm.22170","article-title":"Low-level laser (light) therapy (LLLT) for treatment of hair loss","volume":"46","author":"Avci","year":"2014","journal-title":"Lasers Surg Med"},{"key":"CIT0062-20230512","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40257-013-0060-6","article-title":"Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: A multicenter, randomized, sham device-controlled, Double-blind Study","volume":"15","author":"Jimenez","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"CIT0063-20230512","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00044011-200929050-00001","article-title":"HairMaxLaserComb\u00ae laser phototherapy device in the treatment of male androgenetic alopecia: A randomized, double-blind, sham devicecontrolled","volume":"29","author":"Leavitt","year":"2009","journal-title":"Multicentre Trial Clin Drug Investig"},{"key":"CIT0064-20230512","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/dsu.12200","article-title":"Low-level light therapy for androgenetic alopecia: A 24-week, randomized, double-blind, sham device-controlled multicenter trial","volume":"39","author":"Kim","year":"2013","journal-title":"Dermatol Surg"},{"key":"CIT0065-20230512","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s10103-018-02699-9","article-title":"Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: A 24-week, randomized, double-blind, sham devicecontrolled trial","volume":"34","author":"Suchonwanit","year":"2019","journal-title":"Lasers Med Sci"},{"key":"CIT0066-20230512","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s10103-018-02699-9","article-title":"Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: A 24-week, randomized, double-blind, sham device-controlled trial","volume":"34","author":"Suchonwanit","year":"2019","journal-title":"Lasers Med Sci"},{"key":"CIT0067-20230512","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/lsm.22173","article-title":"The growth of human scalp hair mediated by visible red light laser and LED sources in males","volume":"45","author":"Lanzafame","year":"2013","journal-title":"Lasers Surg Med"},{"key":"CIT0068-20230512","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4103\/ijdvl.IJDVL_1156_16","article-title":"The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia","volume":"84","author":"Faghihi","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"CIT0069-20230512","first-page":"385","article-title":"Role of Low-Level Light Therapy (LLLT) in Androgenetic Alopecia","volume":"14","author":"Pillai","year":"2021","journal-title":"J CutanAesthet Surg"},{"key":"CIT0070-20230512","doi-asserted-by":"crossref","first-page":"37","DOI":"10.33589\/32.2.37","article-title":"The evolution of the promise of hair cloning. How hair cell cloning will fit into your practice","volume":"32","author":"Kemp","year":"2022","journal-title":"Hair Transplant Forum International"}],"container-title":["Journal of Cutaneous and Aesthetic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/JCAS.JCAS_212_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T07:16:52Z","timestamp":1725088612000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcasonline.com\/combination-and-rotational-therapy-in-androgenetic-alopecia\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jcas.jcas_212_22","relation":{},"ISSN":["0974-2077"],"issn-type":[{"value":"0974-2077","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}